300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Android
Internet
Sustainability
Hardware
Biotech
Impact
Proptech
Enterprise
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
New Zealand
Uzbekistan
Australia
Saudi Arabia
Morocco
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Ireland
Paraguay
Japan
South Africa
France
Canada
Georgia
Denmark
Ghana
Iraq
Mali
United Kingdom
Latvia
Malaysia
Portugal
Sierra Leone
Philippines
Rwanda
El Salvador
Tanzania
Senegal
Germany
India
United States
Indonesia
Dominican Republic
Middle East
Asia
Bermuda
Albania
Spain
Argentina
Angola
Europe
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bangladesh
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Douglas Rosenthal, Independent Researcher at Biotechnology Industry Research Assistance Council(BIRAC)

Douglas Rosenthal

Independent Researcher @ Biotechnology Industry Research Assistance Council(BIRAC)

Cleveland, United States

Douglas Rosenthal is a research scientist in the field of biology. Rosenthal was born and lives in Cleveland, Ohio. Rosenthal holds a Bachelor’s, Masters’s and PhD in Biology from the Case Western Reserve University.During the period between 1991 and 1994, Rosenthal did postdoctoral research as a Postdoctoral Fellow at the MRC Laboratory ofMolecular Biology at the University of Cambridge In 1995 he started making researches in the field of biology, in affiliation with the Cleveland Clinic - Lerner Research Institute.Rosenthal started serving as a professor at the Cleveland Institute for Computational Biology in 2005. Doug Rosenthal has also done a number of researches affiliated with this university. He became a member of the Cleveland Center for Membrane and Structural Biology (CCMSB) in 2015.When making his research studies, he relies on molecular structures from electron microscopy (EM), x-ray crystallography, and nuclear magnetic resonance spectroscopy. Rosenthal’s research studies have been featured in many scientific journals.He has been conducting research studies of the molecules that form cells and pathogens. Rosenthal focuses on how pathogens infect and cause disease by producing virulence factors that target host cell molecules. Some of Rosenthal’s studies have contributed to the understanding of the cytoskeleton, organelles and membrane-trafficking intermediates, signal transduction pathways, cell cycle regulators, the organelle/protein recycling machinery, and cell-death pathways. Moreover, his studies have revealed cellular pathways that are crucial for the immune response. The discoveries from Rosenthal studies have been used in the development of host-targeted therapies to treat infectious diseases.Moreover, he has authored two books: Atomic Evidence and The Body’s Motors.

Last updated:

Biotechnology Industry Research Assistance Council(BIRAC)

About Biotechnology Industry Research Assistance Council(BIRAC)

VC Fund · New Delhi, India

Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit Section 8, Schedule B, Public Sector Enterprise, set up by Department of Biotechnology (DBT), Government of India as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research and innovation, addressing nationallyrelevant product development needs.BIRAC is a industry-academia interface and implements its mandate through a wide range of impact initiatives, be it providing access to risk capital through targeted funding, technology transfer, IP management and handholding schemes that help bring innovation excellence to the biotech firms and make them globally competitive. In its Eight years of existence, BIRAC has initiated several schemes, networks and platforms that help to bridge the existing gaps in the industry-academia Innovation research and facilitate novel, high quality affordable products development through cutting edge technologies. BIRAC has initiated partnerships with several national and global partners to collaborate and deliver the salient features of its mandate.Vision“To Stimulate, foster and enhance the strategic research and innovation capabilities of the Indian biotech industry, particularly start-ups and SME’s, for creation of affordable products addressing the needs of the largest section of society”Key StrategiesFoster innovation and entrepreneurship Promote affordable innovation in key social sectors Empowerment of start-ups & small and medium enterprises Contribute through partners for capability enhancement and diffusion of innovation Enable commercialization of discovery Ensure global competitiveness of Indian enterprises BIRAC’s Core ValuesIntegrity Transparency Team work Excellence Commitment BIRAC’s aim is to play a transformative and catalytic role in building a US$ 100 billion Indian bioeconomy. We believe that the agents of change for building the Indian bioeconomy would be biotech start-ups & SMEs & hence our focus is on raising their capabilities

Biotechnology Industry Research Assistance Council(BIRAC) Contacts

NameEmailPhoneSocials
Douglas Rosenthal
Douglas Rosenthal Independent Researcher

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Open Biotechnology Industry Research Assistance Council(BIRAC) full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Android
Internet
Sustainability
Hardware
Biotech
Impact
Proptech
Enterprise
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
New Zealand
Uzbekistan
Australia
Saudi Arabia
Morocco
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Ireland
Paraguay
Japan
South Africa
France
Canada
Georgia
Denmark
Ghana
Iraq
Mali
United Kingdom
Latvia
Malaysia
Portugal
Sierra Leone
Philippines
Rwanda
El Salvador
Tanzania
Senegal
Germany
India
United States
Indonesia
Dominican Republic
Middle East
Asia
Bermuda
Albania
Spain
Argentina
Angola
Europe
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bangladesh
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

FAQ

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Douglas Rosenthal Douglas Rosenthal Find email